Lv14
60 积分 2025-08-11 加入
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
2天前
已完结
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy
2天前
已完结
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): predictors, characteristics, and clinical outcomes
2天前
已完结
Faculty Opinions recommendation of Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes
2天前
已关闭
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
2天前
已完结
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
2天前
已完结
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk
2天前
已完结
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study
2天前
已完结
. Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (>/=85 years) Patients With Newly Diagnosed Atrial Fibrilla‑ tion: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study
2天前
已完结
Anticoagulation in patients with atrial fibrillation and coronary artery disease
5天前
已关闭
皖公网安备34019202002308
